Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

DynaMedex merges the clinical acumen and meticulously curated disease information from DynaMed with the thorough overview of treatment options, expansive drug data, and AI-driven search functionalities of Micromedex. It equips users with evidence-based insights that facilitate superior clinical decision-making and enhance patient outcomes. Clinicians utilizing DynaMedex can effortlessly search, browse, and stay updated on the topics and specialties that are most relevant to their practice, receiving both quick responses and comprehensive insights into their drug inquiries. Delve into this innovative tool and discover how it fosters improved clinical decision-making. Users can swiftly obtain answers to their drug-related questions through intuitive and conversational search features. The "Ask Watson" assistant employs artificial intelligence to streamline access to drug information, eliminating the need for traditional keyword searches in favor of natural language queries, allowing users to communicate in their own words and receive the information they seek efficiently. This seamless integration of AI technology not only saves time but also empowers healthcare professionals to make informed decisions with greater ease.

Description

Rare diseases often lack comprehensive research, resulting in insufficient knowledge about essential elements for an effective drug discovery initiative. Our innovative AI platform, Healnet, addresses these issues by scrutinizing vast amounts of drug and disease data to uncover new connections that may lead to potential treatments. Utilizing cutting-edge technologies throughout the discovery and development process allows us to operate multiple phases simultaneously and on a large scale. The conventional approach of focusing on a single disease, target, and drug is overly simplistic, yet it remains the standard for most pharmaceutical companies. The future of drug discovery is driven by AI, characterized by parallel processes and an absence of rigid hypotheses, fundamentally integrating the three core paradigms of drug discovery into a cohesive strategy. This new paradigm not only enhances efficiency but also fosters creativity in developing solutions for complex health challenges.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

Free
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

EBSCO

Country

United States

Website

www.ebsco.com/clinical-decisions/dynamed-solutions/dynamedex

Vendor Details

Company Name

Healx

Founded

2014

Country

United Kingdom

Website

healx.io/technology/

Product Features

Product Features

Alternatives

DynaMed Reviews

DynaMed

EBSCO

Alternatives

Micromedex Reviews

Micromedex

Merative
75health Reviews

75health

Kaaspro